DAR: EPA RFS Mandates And Q4 Results Will Drive Upside Potential

Analysts have raised their price targets on Darling Ingredients, increasing the fair value estimate from $64.08 to $68.33. They cite updated views on growth, margins, and future P/E assumptions, supported by a series of recent target increases across major research firms.

Analyst Commentary

Recent research highlights a cluster of target price increases and at least one upgrade on Darling Ingredients, with several firms adjusting their models after reviewing updated growth expectations, margin assumptions, and P/E frameworks. These moves give you a window into how the Street is thinking about execution risk, valuation, and the regulatory backdrop.

Bullish Takeaways

Bullish analysts are lifting price targets by a wide range, including single digit and double digit moves such as US$2, US$5, US$7, US$10, US$12, US$13, US$16, and US$20 per share. This signals a more constructive view on what the current business mix could be worth.
One upgrade, paired with a series of higher targets, suggests improving confidence that management can execute on its plan rather than just benefit from one off factors.
Some analysts see regulatory decisions, such as the final EPA RFS volume mandates, as supportive for companies in this space including Darling Ingredients. They factor this into their models as a tailwind for earnings power.
Scotiabank’s move to raise the target from US$45 to US$61 while reiterating an Outperform rating and pointing to Q4 results as a potential support for near term share performance shows that at least part of the Street is comfortable underwriting a higher multiple on recent financial delivery.

Bearish Takeaways

Even with higher targets, analysts are still relying on specific assumptions around growth, margins, and P/E, which can be sensitive to changes in feedstock costs, regulation, or execution slip ups.
The focus on Q4 results as a driver for near term share performance implies that some of the optimism is tied to relatively short term data points rather than a fully de risked long term outlook.
Multiple target hikes clustered around the same period can reflect herd behavior. This means investors should be careful not to treat the new targets as hard anchors for intrinsic value.
Ongoing revisions to models, including separate US$5 and US$10 target increases at BofA and repeated revisions from firms like JPMorgan and Jefferies, show that the valuation case is still being recalibrated rather than fully settled.

What's in the News

Completion of a long running buyback program, with 11,617,466 shares repurchased for US$515.54 million, equal to 7.17% of the company, under the authorization announced on August 13, 2015 (Key Developments).
No additional shares repurchased between September 28, 2025 and March 3, 2026, with reported buybacks of 0 shares for US$0, indicating the program has effectively wrapped up in this period (Key Developments).
The end of this buyback tranche gives you a clear reference point for how much capital has already been returned through repurchases and the scale of share count reduction to date (Key Developments).

Valuation Changes

Fair Value: The estimated fair value has risen from $64.08 to $68.33 per share. This represents a modest upward reset in what analysts think the stock could be worth.
Discount Rate: The discount rate is effectively unchanged at 6.98%, so the updated valuation is not driven by a shift in required return assumptions.
Revenue Growth: Revenue growth assumptions have moved from 4.19% to 4.65%. This reflects a slightly higher view on future top line expansion in dollar terms.
Net Profit Margin: Net profit margin expectations have moved from 21.20% to 13.81%. This is a sizeable reset that points to a more conservative view on future profitability.
Future P/E: The assumed future P/E multiple has increased from 8.48x to 13.70x. This indicates that a larger share of the fair value now comes from a higher valuation multiple rather than higher margin assumptions.

0 views

Key Takeaways

Favorable policy shifts, regulatory support, and product innovation are expected to drive margin expansion, revenue growth, and earnings acceleration across multiple segments.
Diversification into specialty ingredients and global markets enhances operational flexibility, broadens the revenue base, and strengthens overall financial resilience.
Regulatory uncertainty, margin pressure, rising feedstock costs, high leverage, and weak Food segment growth threaten profitability and hinder Darling Ingredients' ability to capitalize on growth opportunities.

Catalysts

About Darling Ingredients

Develops, produces, and sells natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally.What are the underlying business or industry changes driving this perspective?

Policy changes favoring U.S.-sourced renewable diesel feedstocks (higher domestic fat prices, reduced foreign competition) and increasing U.S. biofuel mandates are expected to structurally expand demand and improve pricing power in Darling's Feed and Fuel segments, which should drive higher revenue and margin expansion through 2026 and beyond.
Recent implementation of stricter greenhouse gas reduction requirements in California and the anticipated move higher in LCFS credit prices are set to directly support margin recovery for renewable fuels (DGD), which, once regulatory uncertainties (SRE, RIN, RVO) are resolved later in 2025, are likely to accelerate earnings growth and EBITDA for the Fuel segment.
Ongoing expansion into high-growth, high-margin specialty ingredients via the Nextida JV and rising global demand for health & wellness products (e.g., collagen, functional peptides), backed by scientific validation and early repeat orders, is expected to meaningfully broaden Darling's product portfolio, diversify revenues, and drive Food segment EBITDA growth starting in 2026.
Geographic and product diversification, especially through integration in Brazil and expansion in Europe and the U.K., positions Darling to benefit from population growth and rising protein consumption globally, while providing operational flexibility and stability that should support both top-line growth and resilient net margins.
Investments in operational efficiency and advanced processing technologies are enhancing rendering yields and product innovation, which, combined with strict capital discipline and deleveraging, are expected to improve net margins, boost free cash flow, and set the stage for renewed capital allocation (debt paydown, buybacks) when near-term industry headwinds abate.

Darling Ingredients Earnings and Revenue Growth

Darling Ingredients Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Darling Ingredients's revenue will grow by 4.7% annually over the next 3 years.
Analysts assume that profit margins will increase from 1.0% today to 13.8% in 3 years time.
Analysts expect earnings to reach $971.2 million (and earnings per share of $4.28) by about April 2029, up from $62.8 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.8x on those 2029 earnings, down from 147.7x today. This future PE is lower than the current PE for the US Food industry at 21.3x.
Analysts expect the number of shares outstanding to grow by 0.28% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 6.98%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Ongoing regulatory and policy uncertainty, especially around Renewable Identification Numbers (RINs), small refinery exemptions (SREs), and finalization of Renewable Volume Obligations (RVOs), creates volatility in renewable fuel margins and delays earnings visibility; unpredictable timing could further pressure topline revenue growth and segment earnings.
Prolonged low utilization rates and margin weakness in the renewable diesel/fuel segment-reflected by DGD-1 remaining offline and lower year-to-date DGD EBITDA ($48.7M in 2025 vs $191.7M in 2024)-indicate industry overcapacity and policy-driven demand-deferral risks, which may weigh on future profitability and net margins.
Increased feedstock cost volatility, evidenced by margin compression from fat and used cooking oil (UCO) price lags, coupled with higher procurement costs when raw material prices rise faster than sales prices, risk future gross margin instability and may negatively impact EBITDA.
High leverage and focus on deleveraging constrain near-term growth investments, highlighted by a preliminary leverage ratio still above target (3.34x at end of Q2 2025), potentially limiting Darling Ingredients' ability to capitalize quickly on growth opportunities and pressuring net earnings if market conditions worsen.
Emerging biotechnological competition and slow adoption of new health and wellness products (Nextida), along with tepid or oversupplied collagen/gelatin markets, could slow Food segment growth, potentially translating to lower-than-expected revenue contribution from strategic diversification initiatives.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $68.33 for Darling Ingredients based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $78.0, and the most bearish reporting a price target of just $58.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $7.0 billion, earnings will come to $971.2 million, and it would be trading on a PE ratio of 13.8x, assuming you use a discount rate of 7.0%.
Given the current share price of $58.44, the analyst price target of $68.33 is 14.5% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Darling Ingredients?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

US Renewable Mandates And Specialty Ingredients Will Power Market Evolution